Sanofi Genzyme competitors

Zippia score 4.8

Sanofi Genzyme main competitors are Gilead Sciences, Genentech, and Illumina.

Competitor Summary. See how Sanofi Genzyme compares to its main competitors:

Johnson & Johnson has the most employees (134,500).
Employees at Gilead Sciences earn more than most of the competitors, with an average yearly salary of $99,828.
The oldest company is McNeil Consumer Healthcare, founded in 1879.

Work at Sanofi Genzyme?

Share your experience

Sanofi Genzyme vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Sanofi Genzyme	1981	4.8	Cambridge, MA	1	$4.6B	12,000
Regeneron	1988	4.9	Tarrytown, NY	7	$14.2B	9,123
Amgen	1980	4.8	Thousand Oaks, CA	9	$33.4B	22,000
Gilead Sciences	1987	4.5	Foster City, CA	9	$28.8B	11,800
Merck	1891	4.6	Kenilworth, NJ	31	$64.2B	74,000
Johnson & Johnson	1886	4.7	New Brunswick, NJ	26	$88.8B	134,500
Genentech	1976	4.5	South San Francisco, CA	5	$166.9M	13,638
Medimmune	1987	4.7	Gaithersburg, MD	1	$422.2M	6,030
BioMarin	1997	4.6	San Rafael, CA	4	$2.9B	2,581
Illumina	1998	4.8	San Diego, CA	5	$4.4B	7,800
Biomérieux	1963	4.7	Durham, NC	1	-	6,828
McNeil Consumer Healthcare	1879	4.3	Fort Washington, PA	1	$46.2M	17
Emergent BioSolutions	1998	4.8	Gaithersburg, MD	12	$1.6B	1,834
Caliper Life Sciences	1995	4.5	Hopkinton, MA	1	$109.8M	200
Abbott Molecular	1989	4.3	Des Plaines, IL	1	$74.5M	125
Medtronic	1949	4.7	Minneapolis, MN	26	$17.0B	104,950
ImClone Systems LLC	1984	4.8	Bridgewater, NJ	1	$39.0M	180
Halyard Health	2014	4.4	Alpharetta, GA	3	$1.6B	11,000
MannKind	1991	4.7	Westlake Village, CA	2	$10.0M	233
Advanced Sterilization Products	1987	4.5	Irvine, CA	1	$83.0M	1,074
Namsa	1967	4.2	Northwood, OH	5	$13.0M	142

Rate how well Sanofi Genzyme differentiates itself from its competitors.

Sanofi Genzyme salaries vs competitors

Among Sanofi Genzyme competitors, employees at Gilead Sciences earn the most with an average yearly salary of $99,828.

Compare Sanofi Genzyme salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Sanofi Genzyme	$84,495	$40.62	-
Regeneron	$85,589	$41.15	-
Amgen	$93,349	$44.88	-
Gilead Sciences	$99,828	$47.99	-
Merck	$90,328	$43.43	-
Johnson & Johnson	$76,686	$36.87	-

Compare Sanofi Genzyme job title salaries vs competitors

Company	Highest salary	Hourly salary
Sanofi Genzyme	$97,617	$46.93
Genentech	$109,601	$52.69
BioMarin	$105,084	$50.52
Medimmune	$103,730	$49.87
Abbott Molecular	$103,546	$49.78
McNeil Consumer Healthcare	$101,927	$49.00
Advanced Sterilization Products	$101,146	$48.63
Amgen	$100,980	$48.55
Namsa	$100,742	$48.43
Halyard Health	$100,595	$48.36
MannKind	$99,282	$47.73
Regeneron	$99,054	$47.62
Illumina	$99,015	$47.60
Biomérieux	$98,960	$47.58
Emergent BioSolutions	$98,460	$47.34
Merck	$96,871	$46.57
ImClone Systems LLC	$96,460	$46.37
Medtronic	$95,032	$45.69
Caliper Life Sciences	$92,676	$44.56
Gilead Sciences	$90,098	$43.32

Do you work at Sanofi Genzyme?

Does Sanofi Genzyme effectively differentiate itself from competitors?

Sanofi Genzyme jobs

Sanofi Genzyme demographics vs competitors

Compare gender at Sanofi Genzyme vs competitors

Job title	Male	Female
BioMarin	50%	50%
Sanofi Genzyme	51%	49%
Emergent BioSolutions	56%	44%
Gilead Sciences	56%	44%
Amgen	57%	43%
Illumina	62%	38%

Male

Female

100%

75%

50%

25%

Illumina

Amgen

Gilead Sciences

Emergent BioSolutions

Sanofi Genzyme

BioMarin

25%

50%

75%

100%

Compare race at Sanofi Genzyme vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Sanofi Genzyme	61%	14%	7%	14%	4%	9.8
Amgen	49%	24%	7%	15%	5%	9.7
BioMarin	43%	20%	8%	23%	7%	9.6
Emergent BioSolutions	60%	11%	16%	9%	4%	9.6
Gilead Sciences	44%	20%	8%	23%	6%	9.8
Illumina	46%	23%	7%	20%	5%	9.7

Sanofi Genzyme and similar companies CEOs

CEOBio

Robert A. Bradway

Amgen

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

Jean Jacques Bienaime

BioMarin

Jean-Jacques Bienaime is a Board Member at Biotechnology Innovation Organization - BIO, Director at INCYTE CORP, and Chairman/CEO at BioMarin Pharmaceutical Inc and is based in Novato, California. He has experience at Rhône Poulenc Rorer and has worked as President/CEO at GENENCOR INTERNATIONAL INC, Board Member at NeurogesX Inc, and Marketing Director at Genentech. Jean attended ESCP Europe, Ecole Superieure de Commerce de Paris between 1974 and 1976, and University of Pennsylvania.

Robert Kramer Sr.

Emergent BioSolutions

Robert Kramer is a President & Chief Executive Officer at EMERGENT BIOSOLUTIONS INC., Board Member at EMERGENT BIOSOLUTIONS INC., and Interim Exec VP:Services at EMERGENT BIOSOLUTIONS INC. and is based in Lansing, Michigan. He has experience at PHARMACIA CORP and has worked as Pres:Biosciences Div at EMERGENT BIOSOLUTIONS INC., Consultant at EMERGENT BIOSOLUTIONS INC., and President at Emergent Biodefense Ops Lansg. Robert works or has worked as Chief Executive Officer at Emergent Biodefense Operations. He studied at WESTERN KENTUCKY UNIVERSITY between 1980 and 1983 and Clemson University between 1975 and 1979.

Daniel O’Day

Gilead Sciences

Robert Abernathy

Halyard Health

Francis A. Desouza

Illumina

Francis Aurelio deSouza (born December 2, 1970) is an American entrepreneur and business executive. He is the president and chief executive officer (CEO) of Illumina and a member of the Board of Directors of The Walt Disney Company.

Joaquin Duato

Johnson & Johnson

Michael E. Castagna

MannKind

Michael Castagna is a Board Member at MANNKIND CORP and Chief Executive Officer at MANNKIND CORP and is based in Westlake Village, California. He has worked as Vice President & Head, Biopharmaceuticals North America at Sandoz; Director, Endocrinology Marketing at Healthcare Business of Merck; and VP/Global Head:Commercial at Amgen. Michael attended Massachusetts College of Pharmacy and Health Sciences between 2012 and 2014, The Wharton School between 2003 and 2005, and Philadelphia College of Pharmacy & Science.

Robert M. Davis

Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Alexandre Mérieux

Biomérieux